MAR 16, 2020 2:39 PM PDT

Cannabis Reduces ADHD Med Use in New Study

WRITTEN BY: Julia Travers

As the legalization of medical cannabis increases in the U.S. and around the globe, its effects on a variety of conditions and behaviors are under examination. In Israel, medical marijuana was first approved for cancer patients, those with chronic pain, and others in the 90s. Use has since expanded, with tens of thousands of people registered as users and Israel's Ministry of Health funding related research. The Evelyn Gruss Lipper Charitable Foundation also funds studies in this area and recently backed an exploration of how medical cannabis use affected the prescription drug intake of Israeli ADHD patients. 

In the U.S., it is estimated that about 6.1 million children have been diagnosed with ADHD to date. ADHD symptoms “start in early childhood and continue into adulthood. In some cases, ADHD is not recognized or diagnosed until the person is an adult,” according to the Mayo Clinic

The recent study focused on 53 Israeli medical cannabis patients who had an ADHD diagnosis. Most had previously gotten the cannabis licenses in relation to chronic pain or cancer treatment. Participants who used medical marijuana were found to use fewer prescription drugs or to stop taking ADHD medications altogether. 

Cannabis consumers were divided into high- and low-dose groups and 27 different combinations of cultivar varieties were trialed. “The cannabinoids most associated with reduced or eliminated ADHD medication use” included CBN, THC, THCV and CBD, Marijuana Moment reported. 

“These findings reveal that the higher-dose consumption of MC components (phyto-cannabinoids and terpenes) is associated with ADHD medication reduction… However, more studies are needed in order to fully understand if cannabis and its constituents can be used for management of ADHD,” the authors concluded. Jeffrey Y. Hergenrather, Joshua Aviram, Yelena Vysotski, Salvatore Campisi-Pinto, Gil M. Lewitus and David Meiri conducted the research. “Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients,” was published in the Rambam Maimonides Medical Journal in January 2020.

Article Sources:

Rambam Maimonides Medical Journal

Marijuana Moment

Mayo Clinic

 

About the Author
  • Julia Travers is a writer, artist and teacher. She frequently covers science, tech, conservation and the arts. She enjoys solutions journalism. Find more of her work at jtravers.journoportfolio.com.
You May Also Like
APR 25, 2020
Cannabis Sciences
Researchers Trial Cannabis to Treat COVID-19
APR 25, 2020
Researchers Trial Cannabis to Treat COVID-19
Researchers in Israel are investigating the potential for cannabis-derived products to treat patients with COVID-19. So ...
MAY 12, 2020
Cannabis Sciences
Cannabis Use Not Linked to Low IQ
MAY 12, 2020
Cannabis Use Not Linked to Low IQ
While 12% of adults in the US claim to have smoked cannabis, the same figure stands at 22% for those aged between 18 and ...
JUN 20, 2020
Cannabis Sciences
Prolonged Cannabis Use May Prevent Migraines
JUN 20, 2020
Prolonged Cannabis Use May Prevent Migraines
Between 1% and 2% of the world's population suffers from chronic migraines. Researchers from Israel have now found t ...
JUL 10, 2020
Cannabis Sciences
How Cannabis Compound THC Makes You Less Sociable
JUL 10, 2020
How Cannabis Compound THC Makes You Less Sociable
Although previous research found that cannabis use may lead to social withdrawal, until now, the mechanisms behind the p ...
AUG 05, 2020
Cannabis Sciences
Cannabis Provides Short Term Relief for Depression
AUG 05, 2020
Cannabis Provides Short Term Relief for Depression
Researchers from Yale University have found that cannabis has short-term antidepressant effects in the vast majority of ...
AUG 12, 2020
Health & Medicine
Boomers Use Cannabis Mostly for Ailments; Millennials for Recreation
AUG 12, 2020
Boomers Use Cannabis Mostly for Ailments; Millennials for Recreation
A survey by marijuana dispensary chain Verilife has found that older and younger cannabis consumers have very different ...
Loading Comments...